Lilavati Hospital set for international expansion with OPD in Kazakhstan
Lilavati Hospital is set to launch its first operational healthcare facility outside India in Kazakhstan in early September 2026. The super-speciality OPD will offer consultations and second opinions across multiple specialties, with complex cases connected to the hospital's Mumbai facility for advanced treatment.
Mumbai: Lilavati Hospital is set to begin its international expansion with the launch of a super-speciality outpatient department (OPD) facility in Kazakhstan in early September 2026.
The facility will become the hospital’s first operational healthcare facility outside India and will provide specialist consultations, second opinions and advanced treatment planning to patients in Central Asia.
According to The Daily, the Kazakhstan facility will offer consultations and second opinions across several super-speciality areas, including oncology, liver and hepatobiliary care, kidney and transplantation, cardiac sciences, neurology and neurosurgery, IVF and reproductive medicine, gastroenterology, orthopaedics, urology, endocrinology and diabetes, paediatrics, and pulmonology. The centre is aimed at bringing Lilavati Hospital’s specialist expertise closer to patients in the region.
Patients with complex medical conditions requiring advanced treatment or surgery will be connected with Lilavati Hospital in Mumbai. This will provide patients with a structured pathway to access specialised care at the Mumbai facility when treatment requirements go beyond the services available through the Kazakhstan centre, reports India Med Today.
Lilavati Hospital has more than three decades of healthcare experience and has around 375 consultants and specialists working across more than 40 medical and surgical specialities. Its areas of expertise include transplantation, oncology, cardiac sciences, neurosciences, robotic and minimally invasive surgery, gastrointestinal and hepatobiliary surgery, and IVF.
Dr Ravindra Karanjekar, CEO of Lilavati Hospital and Research Centre, said, “Our expansion into Kazakhstan is an important step in our vision of taking trusted Indian healthcare expertise to the world. We want to bring Lilavati’s clinical expertise, specialist consultations and advanced treatment pathways closer to patients in Central Asia. At the same time, this initiative is about building a sustainable India–Kazakhstan healthcare ecosystem through specialist consultations, telemedicine, medical education and doctor-to-doctor collaboration. For complex cases, patients will have a structured pathway to access advanced care at Lilavati Hospital Mumbai. We see Kazakhstan as the first step to building our presence across the wider Central Asian region.”
The initiative will also create local employment opportunities while maintaining Lilavati Hospital’s clinical protocols and standards. The Kazakhstan centre is expected to serve as the first step in the hospital’s plans to build a wider international healthcare network.
Also Read:Lilavati Hospital Performs India’s First Intravascular Ultrasound-Guided TAVR Procedure
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.